← Mechanisms of action
Adrenergic receptor alpha-2
PROTEIN FAMILYHomo sapiens
Linked proteins
Drugs acting on this target (14)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| apraclonidine (iopidine) | Agonist | approved | Small molecule | Adrenergic receptor alpha-2 agonist |
| brimonidine (alphagan) | Agonist | approved | Small molecule | Adrenergic receptor alpha-2 agonist |
| clonidine (catapres) | Agonist | approved | Small molecule | Adrenergic receptor alpha-2 agonist |
| dexmedetomidine (precedex) | Agonist | approved | Small molecule | Adrenergic receptor alpha-2 agonist |
| guanabenz (wytensin) | Agonist | approved | Small molecule | Adrenergic receptor alpha-2 agonist |
| guanfacine (tenex) | Agonist | approved | Small molecule | Adrenergic receptor alpha-2 agonist |
| lofexidine (lucemyra) | Agonist | approved | Small molecule | Adrenergic receptor alpha-2 agonist |
| methyldopa (aldomet) | Agonist | approved | Small molecule | Adrenergic receptor alpha-2 agonist |
| radolmidine | Agonist | experimental | Small molecule | Adrenergic receptor alpha-2 agonist |
| tizanidine (zanaflex) | Agonist | approved | Small molecule | Adrenergic receptor alpha-2 agonist |
| celiprolol | Antagonist | experimental | Small molecule | Adrenergic receptor alpha-2 antagonist |
| fipamezole | Antagonist | experimental | Small molecule | Adrenergic receptor alpha-2 antagonist |
| idazoxan | Antagonist | experimental | Small molecule | Adrenergic receptor alpha-2 antagonist |
| mirtazapine (remeron) | Antagonist | approved | Small molecule | Adrenergic receptor alpha-2 antagonist |